The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baccarini, M.
Right arrow Articles by Lohmann-Matthes, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baccarini, M.
Right arrow Articles by Lohmann-Matthes, M. L.

The Journal of Immunology, Vol 142, Issue 1 118-125, Copyright © 1989 by American Association of Immunologists


ARTICLES

Effect of human recombinant IL-2 on murine macrophage precursors. Involvement of a receptor distinct from the p55 (Tac) protein

M Baccarini, R Schwinzer and ML Lohmann-Matthes
Department of Immunobiology, Fraunhofer-Institut fur Toxikologie und Aerosolforschung, Hannover, FRG.

Homogeneous populations of bone marrow-derived murine macrophage precursors are able to respond to human rIL-2. A prolonged exposure to the lymphokine results in proliferation and in the final differentiation of macrophage precursors to mature macrophages, as shown by follow-up of the antigenic profile by means of cytofluorograph analysis. The frequency of the IL-2-responding cells was 1/48 as determined by limiting dilution analysis, and no cell death was evidenced in soft agar cultures. An analysis of the IL-2-binding sites conducted on bone marrow-derived macrophage precursors revealed the presence of 4000 binding sites with intermediate affinity (Kd approximately 3 x 10(-9)). Bone marrow-derived macrophage precursors did not react, even after prolonged culture in IL-2-conditioned media, with mAb recognizing the binding site (AMT-13, 3C7) or a binding site- associate molecule (7D4) of a Mr 50,000 to 60,000 component of the IL- 2R expressed by the IL-2-dependent T cell line CTLL-2. Cross-linking studies showed the presence of a single binding protein, with an apparent Mr of 70,000. Macrophage precursors also proved able to internalize human rIL-2 within the first 20 min of incubation at 37 degrees C. The implications of these findings are discussed.


This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
Y. Kimura, H. Mizuno, K. Satake, H. Tahara, and M. Tsukuda
Effects of Combined Therapy With Interleukin 2 and Interleukin 12 Gene-Transfected Tumor Vaccine for Head and Neck Carcinoma
Arch Otolaryngol Head Neck Surg, November 1, 2003; 129(11): 1181 - 1185.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Billia, M. Barbara, J. McEwen, M. Trevisan, and N. N. Iscove
Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts
Blood, April 15, 2001; 97(8): 2257 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. P. Perera, C. K. Goldman, and T. A. Waldmann
Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice
PNAS, April 5, 2001; (2001) 81080298.
[Abstract] [Full Text]


Home page
BloodHome page
T. Reya, N. V. Contractor, M. S. Couzens, M. A. Wasik, S. G. Emerson, and S. R. Carding
Abnormal Myelocytic Cell Development in Interleukin-2 (IL-2)-Deficient Mice: Evidence for the Involvement of IL-2 in Myelopoiesis
Blood, April 15, 1998; 91(8): 2935 - 2947.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. P. Perera, C. K. Goldman, and T. A. Waldmann
Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice
PNAS, April 24, 2001; 98(9): 5146 - 5151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.